Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

378

HTML

3082

Figures (1-2)

194

Tables (1-2)

144

Sum=3798

Publishing Process of This Article

Item

Count

Browse

1124

Download

964

Sum=2088

Feb 7, 2013 (publication date) through Aug 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Feb 7, 2013; 19(5): 761-768
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.761

Full Size Figure Download Figure

Figure 2 Funnel plot of the results obtained from studies comparing overall morbidity. RR: Risk ratio.

Citation: Li DB, Ye F, Wu XR, Wu LP, Chen JX, Li B, Zhou YM. Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases. World J Gastroenterol 2013; 19(5): 761-768
URL: https://www.wjgnet.com/1007-9327/full/v19/i5/761.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i5.761